nodes	percent_of_prediction	percent_of_DWPC	metapath
Ergotamine—migraine—Cyproheptadine—allergic rhinitis	0.541	1	CpDpCtD
Ergotamine—HTR2B—Cyproheptadine—allergic rhinitis	0.0634	0.159	CbGbCtD
Ergotamine—SLC6A2—Cyproheptadine—allergic rhinitis	0.0412	0.104	CbGbCtD
Ergotamine—HTR2C—Cyproheptadine—allergic rhinitis	0.0412	0.104	CbGbCtD
Ergotamine—HTR1A—Cyproheptadine—allergic rhinitis	0.0389	0.0976	CbGbCtD
Ergotamine—HTR2A—Cyproheptadine—allergic rhinitis	0.0372	0.0933	CbGbCtD
Ergotamine—DRD2—Cyproheptadine—allergic rhinitis	0.0343	0.086	CbGbCtD
Ergotamine—CYP1A2—Desloratadine—allergic rhinitis	0.0198	0.0497	CbGbCtD
Ergotamine—ABCB1—Desloratadine—allergic rhinitis	0.0173	0.0435	CbGbCtD
Ergotamine—CYP1A2—Diphenhydramine—allergic rhinitis	0.0114	0.0286	CbGbCtD
Ergotamine—CYP3A4—Flunisolide—allergic rhinitis	0.0104	0.026	CbGbCtD
Ergotamine—ABCB1—Loratadine—allergic rhinitis	0.00995	0.025	CbGbCtD
Ergotamine—CYP3A4—Olopatadine—allergic rhinitis	0.00976	0.0245	CbGbCtD
Ergotamine—ABCB1—Methylprednisolone—allergic rhinitis	0.0091	0.0228	CbGbCtD
Ergotamine—CYP3A4—Montelukast—allergic rhinitis	0.00596	0.015	CbGbCtD
Ergotamine—CYP3A4—Loratadine—allergic rhinitis	0.00596	0.015	CbGbCtD
Ergotamine—ABCB1—Betamethasone—allergic rhinitis	0.00592	0.0148	CbGbCtD
Ergotamine—ABCB1—Prednisolone—allergic rhinitis	0.00584	0.0147	CbGbCtD
Ergotamine—ABCB1—Hydrocortisone—allergic rhinitis	0.00553	0.0139	CbGbCtD
Ergotamine—CYP3A4—Methylprednisolone—allergic rhinitis	0.00545	0.0137	CbGbCtD
Ergotamine—CYP3A4—Triamcinolone—allergic rhinitis	0.00413	0.0104	CbGbCtD
Ergotamine—CYP3A4—Betamethasone—allergic rhinitis	0.00354	0.0089	CbGbCtD
Ergotamine—CYP3A4—Prednisolone—allergic rhinitis	0.0035	0.00878	CbGbCtD
Ergotamine—ABCB1—Dexamethasone—allergic rhinitis	0.00344	0.00864	CbGbCtD
Ergotamine—CYP3A4—Hydrocortisone—allergic rhinitis	0.00331	0.00832	CbGbCtD
Ergotamine—CYP3A4—Dexamethasone—allergic rhinitis	0.00206	0.00517	CbGbCtD
Ergotamine—Numbness—Flunisolide—allergic rhinitis	0.00121	0.0315	CcSEcCtD
Ergotamine—Sensory loss—Flunisolide—allergic rhinitis	0.00116	0.0301	CcSEcCtD
Ergotamine—Hypoaesthesia—Olopatadine—allergic rhinitis	0.000718	0.0187	CcSEcCtD
Ergotamine—Vertigo—Cyproheptadine—allergic rhinitis	0.000679	0.0177	CcSEcCtD
Ergotamine—Myalgia—Desloratadine—allergic rhinitis	0.000625	0.0163	CcSEcCtD
Ergotamine—Tachycardia—Cyproheptadine—allergic rhinitis	0.000602	0.0157	CcSEcCtD
Ergotamine—Tachycardia—Desloratadine—allergic rhinitis	0.000585	0.0153	CcSEcCtD
Ergotamine—Paraesthesia—Cyproheptadine—allergic rhinitis	0.000554	0.0144	CcSEcCtD
Ergotamine—Vertigo—Dimenhydrinate—allergic rhinitis	0.000552	0.0144	CcSEcCtD
Ergotamine—Vertigo—Diphenhydramine—allergic rhinitis	0.000552	0.0144	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Desloratadine—allergic rhinitis	0.000546	0.0142	CcSEcCtD
Ergotamine—Hypoaesthesia—Cetirizine—allergic rhinitis	0.000509	0.0133	CcSEcCtD
Ergotamine—Hypoaesthesia—Flunisolide—allergic rhinitis	0.0005	0.013	CcSEcCtD
Ergotamine—Tachycardia—Dimenhydrinate—allergic rhinitis	0.000489	0.0128	CcSEcCtD
Ergotamine—Tachycardia—Diphenhydramine—allergic rhinitis	0.000489	0.0128	CcSEcCtD
Ergotamine—Paraesthesia—Dimenhydrinate—allergic rhinitis	0.00045	0.0117	CcSEcCtD
Ergotamine—Paraesthesia—Diphenhydramine—allergic rhinitis	0.00045	0.0117	CcSEcCtD
Ergotamine—Asthenia—Cyproheptadine—allergic rhinitis	0.000442	0.0115	CcSEcCtD
Ergotamine—Pain—Olopatadine—allergic rhinitis	0.000438	0.0114	CcSEcCtD
Ergotamine—Asthenia—Desloratadine—allergic rhinitis	0.00043	0.0112	CcSEcCtD
Ergotamine—Hypoaesthesia—Montelukast—allergic rhinitis	0.000427	0.0111	CcSEcCtD
Ergotamine—Pruritus—Desloratadine—allergic rhinitis	0.000424	0.0111	CcSEcCtD
Ergotamine—Hypertension—Loratadine—allergic rhinitis	0.000409	0.0107	CcSEcCtD
Ergotamine—Myalgia—Loratadine—allergic rhinitis	0.000403	0.0105	CcSEcCtD
Ergotamine—Vertigo—Cetirizine—allergic rhinitis	0.0004	0.0104	CcSEcCtD
Ergotamine—Vertigo—Flunisolide—allergic rhinitis	0.000393	0.0103	CcSEcCtD
Ergotamine—Vomiting—Cyproheptadine—allergic rhinitis	0.000392	0.0102	CcSEcCtD
Ergotamine—Hypertension—Cetirizine—allergic rhinitis	0.000384	0.01	CcSEcCtD
Ergotamine—Vomiting—Desloratadine—allergic rhinitis	0.000381	0.00994	CcSEcCtD
Ergotamine—Myalgia—Cetirizine—allergic rhinitis	0.000379	0.00988	CcSEcCtD
Ergotamine—Hypertension—Flunisolide—allergic rhinitis	0.000378	0.00986	CcSEcCtD
Ergotamine—Tachycardia—Loratadine—allergic rhinitis	0.000377	0.00983	CcSEcCtD
Ergotamine—Myalgia—Flunisolide—allergic rhinitis	0.000373	0.00972	CcSEcCtD
Ergotamine—Asthenia—Olopatadine—allergic rhinitis	0.000368	0.00959	CcSEcCtD
Ergotamine—Nausea—Cyproheptadine—allergic rhinitis	0.000366	0.00955	CcSEcCtD
Ergotamine—Pruritus—Olopatadine—allergic rhinitis	0.000363	0.00945	CcSEcCtD
Ergotamine—Asthenia—Dimenhydrinate—allergic rhinitis	0.00036	0.00938	CcSEcCtD
Ergotamine—Asthenia—Diphenhydramine—allergic rhinitis	0.00036	0.00938	CcSEcCtD
Ergotamine—Nausea—Desloratadine—allergic rhinitis	0.000356	0.00928	CcSEcCtD
Ergotamine—Tachycardia—Cetirizine—allergic rhinitis	0.000355	0.00925	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Loratadine—allergic rhinitis	0.000352	0.00917	CcSEcCtD
Ergotamine—Tachycardia—Flunisolide—allergic rhinitis	0.000349	0.00909	CcSEcCtD
Ergotamine—Paraesthesia—Loratadine—allergic rhinitis	0.000347	0.00904	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Cetirizine—allergic rhinitis	0.000331	0.00863	CcSEcCtD
Ergotamine—Pain—Loratadine—allergic rhinitis	0.00033	0.00861	CcSEcCtD
Ergotamine—Paraesthesia—Cetirizine—allergic rhinitis	0.000326	0.00851	CcSEcCtD
Ergotamine—Vomiting—Olopatadine—allergic rhinitis	0.000326	0.0085	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Flunisolide—allergic rhinitis	0.000326	0.00849	CcSEcCtD
Ergotamine—Vomiting—Dimenhydrinate—allergic rhinitis	0.000319	0.00831	CcSEcCtD
Ergotamine—Vomiting—Diphenhydramine—allergic rhinitis	0.000319	0.00831	CcSEcCtD
Ergotamine—Myalgia—Montelukast—allergic rhinitis	0.000318	0.00829	CcSEcCtD
Ergotamine—Pain—Cetirizine—allergic rhinitis	0.000311	0.0081	CcSEcCtD
Ergotamine—Pain—Flunisolide—allergic rhinitis	0.000306	0.00797	CcSEcCtD
Ergotamine—Nausea—Olopatadine—allergic rhinitis	0.000304	0.00794	CcSEcCtD
Ergotamine—Nausea—Diphenhydramine—allergic rhinitis	0.000298	0.00777	CcSEcCtD
Ergotamine—Nausea—Dimenhydrinate—allergic rhinitis	0.000298	0.00777	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Montelukast—allergic rhinitis	0.000278	0.00724	CcSEcCtD
Ergotamine—Asthenia—Loratadine—allergic rhinitis	0.000277	0.00722	CcSEcCtD
Ergotamine—Paraesthesia—Montelukast—allergic rhinitis	0.000274	0.00713	CcSEcCtD
Ergotamine—Asthenia—Cetirizine—allergic rhinitis	0.000261	0.0068	CcSEcCtD
Ergotamine—Pain—Montelukast—allergic rhinitis	0.000261	0.00679	CcSEcCtD
Ergotamine—Pruritus—Cetirizine—allergic rhinitis	0.000257	0.0067	CcSEcCtD
Ergotamine—Asthenia—Flunisolide—allergic rhinitis	0.000256	0.00668	CcSEcCtD
Ergotamine—Pruritus—Flunisolide—allergic rhinitis	0.000253	0.00659	CcSEcCtD
Ergotamine—Vomiting—Loratadine—allergic rhinitis	0.000246	0.0064	CcSEcCtD
Ergotamine—Bradycardia—Prednisolone—allergic rhinitis	0.000241	0.0063	CcSEcCtD
Ergotamine—Bradycardia—Hydrocortisone—allergic rhinitis	0.000236	0.00615	CcSEcCtD
Ergotamine—Vomiting—Cetirizine—allergic rhinitis	0.000231	0.00602	CcSEcCtD
Ergotamine—Nausea—Loratadine—allergic rhinitis	0.000229	0.00598	CcSEcCtD
Ergotamine—Vomiting—Flunisolide—allergic rhinitis	0.000227	0.00592	CcSEcCtD
Ergotamine—Bradycardia—Triamcinolone—allergic rhinitis	0.000222	0.00579	CcSEcCtD
Ergotamine—Bradycardia—Methylprednisolone—allergic rhinitis	0.000222	0.00578	CcSEcCtD
Ergotamine—Asthenia—Montelukast—allergic rhinitis	0.000219	0.0057	CcSEcCtD
Ergotamine—Nausea—Cetirizine—allergic rhinitis	0.000216	0.00563	CcSEcCtD
Ergotamine—Pruritus—Montelukast—allergic rhinitis	0.000216	0.00562	CcSEcCtD
Ergotamine—Nausea—Flunisolide—allergic rhinitis	0.000212	0.00553	CcSEcCtD
Ergotamine—Bradycardia—Betamethasone—allergic rhinitis	0.000201	0.00525	CcSEcCtD
Ergotamine—Bradycardia—Dexamethasone—allergic rhinitis	0.000201	0.00525	CcSEcCtD
Ergotamine—Vomiting—Montelukast—allergic rhinitis	0.000194	0.00505	CcSEcCtD
Ergotamine—Vertigo—Prednisolone—allergic rhinitis	0.000185	0.00484	CcSEcCtD
Ergotamine—Vertigo—Hydrocortisone—allergic rhinitis	0.000181	0.00472	CcSEcCtD
Ergotamine—Nausea—Montelukast—allergic rhinitis	0.000181	0.00472	CcSEcCtD
Ergotamine—Hypertension—Prednisolone—allergic rhinitis	0.000178	0.00465	CcSEcCtD
Ergotamine—Hypertension—Hydrocortisone—allergic rhinitis	0.000174	0.00454	CcSEcCtD
Ergotamine—Myalgia—Hydrocortisone—allergic rhinitis	0.000172	0.00448	CcSEcCtD
Ergotamine—Vertigo—Triamcinolone—allergic rhinitis	0.000171	0.00445	CcSEcCtD
Ergotamine—Vertigo—Methylprednisolone—allergic rhinitis	0.00017	0.00444	CcSEcCtD
Ergotamine—Tachycardia—Prednisolone—allergic rhinitis	0.000164	0.00429	CcSEcCtD
Ergotamine—Hypertension—Triamcinolone—allergic rhinitis	0.000164	0.00427	CcSEcCtD
Ergotamine—Hypertension—Methylprednisolone—allergic rhinitis	0.000164	0.00426	CcSEcCtD
Ergotamine—Myalgia—Triamcinolone—allergic rhinitis	0.000162	0.00421	CcSEcCtD
Ergotamine—Myalgia—Methylprednisolone—allergic rhinitis	0.000161	0.00421	CcSEcCtD
Ergotamine—Tachycardia—Hydrocortisone—allergic rhinitis	0.000161	0.00419	CcSEcCtD
Ergotamine—Vertigo—Betamethasone—allergic rhinitis	0.000155	0.00404	CcSEcCtD
Ergotamine—Vertigo—Dexamethasone—allergic rhinitis	0.000155	0.00404	CcSEcCtD
Ergotamine—Paraesthesia—Prednisolone—allergic rhinitis	0.000151	0.00394	CcSEcCtD
Ergotamine—Tachycardia—Triamcinolone—allergic rhinitis	0.000151	0.00394	CcSEcCtD
Ergotamine—Tachycardia—Methylprednisolone—allergic rhinitis	0.000151	0.00393	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	0.00015	0.00391	CcSEcCtD
Ergotamine—Hypertension—Betamethasone—allergic rhinitis	0.000149	0.00388	CcSEcCtD
Ergotamine—Hypertension—Dexamethasone—allergic rhinitis	0.000149	0.00388	CcSEcCtD
Ergotamine—Paraesthesia—Hydrocortisone—allergic rhinitis	0.000148	0.00385	CcSEcCtD
Ergotamine—Myalgia—Dexamethasone—allergic rhinitis	0.000147	0.00382	CcSEcCtD
Ergotamine—Myalgia—Betamethasone—allergic rhinitis	0.000147	0.00382	CcSEcCtD
Ergotamine—Pain—Prednisolone—allergic rhinitis	0.000144	0.00376	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	0.000141	0.00368	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	0.000141	0.00367	CcSEcCtD
Ergotamine—Pain—Hydrocortisone—allergic rhinitis	0.000141	0.00367	CcSEcCtD
Ergotamine—Paraesthesia—Triamcinolone—allergic rhinitis	0.000139	0.00363	CcSEcCtD
Ergotamine—Paraesthesia—Methylprednisolone—allergic rhinitis	0.000139	0.00362	CcSEcCtD
Ergotamine—Tachycardia—Dexamethasone—allergic rhinitis	0.000137	0.00358	CcSEcCtD
Ergotamine—Tachycardia—Betamethasone—allergic rhinitis	0.000137	0.00358	CcSEcCtD
Ergotamine—Pain—Triamcinolone—allergic rhinitis	0.000133	0.00345	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	0.000128	0.00334	CcSEcCtD
Ergotamine—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	0.000128	0.00334	CcSEcCtD
Ergotamine—Paraesthesia—Dexamethasone—allergic rhinitis	0.000126	0.00329	CcSEcCtD
Ergotamine—Paraesthesia—Betamethasone—allergic rhinitis	0.000126	0.00329	CcSEcCtD
Ergotamine—Pain—Dexamethasone—allergic rhinitis	0.00012	0.00313	CcSEcCtD
Ergotamine—Pain—Betamethasone—allergic rhinitis	0.00012	0.00313	CcSEcCtD
Ergotamine—Asthenia—Hydrocortisone—allergic rhinitis	0.000118	0.00308	CcSEcCtD
Ergotamine—Pruritus—Hydrocortisone—allergic rhinitis	0.000116	0.00304	CcSEcCtD
Ergotamine—Asthenia—Triamcinolone—allergic rhinitis	0.000111	0.0029	CcSEcCtD
Ergotamine—Asthenia—Methylprednisolone—allergic rhinitis	0.000111	0.00289	CcSEcCtD
Ergotamine—Pruritus—Triamcinolone—allergic rhinitis	0.00011	0.00286	CcSEcCtD
Ergotamine—Pruritus—Methylprednisolone—allergic rhinitis	0.000109	0.00285	CcSEcCtD
Ergotamine—Vomiting—Hydrocortisone—allergic rhinitis	0.000105	0.00273	CcSEcCtD
Ergotamine—Asthenia—Dexamethasone—allergic rhinitis	0.000101	0.00263	CcSEcCtD
Ergotamine—Asthenia—Betamethasone—allergic rhinitis	0.000101	0.00263	CcSEcCtD
Ergotamine—Nausea—Prednisolone—allergic rhinitis	0.0001	0.00261	CcSEcCtD
Ergotamine—Pruritus—Betamethasone—allergic rhinitis	9.95e-05	0.00259	CcSEcCtD
Ergotamine—Pruritus—Dexamethasone—allergic rhinitis	9.95e-05	0.00259	CcSEcCtD
Ergotamine—Vomiting—Triamcinolone—allergic rhinitis	9.85e-05	0.00257	CcSEcCtD
Ergotamine—Vomiting—Methylprednisolone—allergic rhinitis	9.83e-05	0.00256	CcSEcCtD
Ergotamine—Nausea—Hydrocortisone—allergic rhinitis	9.78e-05	0.00255	CcSEcCtD
Ergotamine—Nausea—Triamcinolone—allergic rhinitis	9.2e-05	0.0024	CcSEcCtD
Ergotamine—Nausea—Methylprednisolone—allergic rhinitis	9.18e-05	0.00239	CcSEcCtD
Ergotamine—Vomiting—Dexamethasone—allergic rhinitis	8.94e-05	0.00233	CcSEcCtD
Ergotamine—Vomiting—Betamethasone—allergic rhinitis	8.94e-05	0.00233	CcSEcCtD
Ergotamine—Nausea—Betamethasone—allergic rhinitis	8.35e-05	0.00218	CcSEcCtD
Ergotamine—Nausea—Dexamethasone—allergic rhinitis	8.35e-05	0.00218	CcSEcCtD
Ergotamine—HTR1F—Signaling Pathways—PTGDR2—allergic rhinitis	4.51e-05	0.002	CbGpPWpGaD
Ergotamine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.5e-05	0.002	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—PTGDR2—allergic rhinitis	4.49e-05	0.00199	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR ligand binding—TAC1—allergic rhinitis	4.48e-05	0.00199	CbGpPWpGaD
Ergotamine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.43e-05	0.00197	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—CYSLTR1—allergic rhinitis	4.37e-05	0.00194	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—TAC1—allergic rhinitis	4.37e-05	0.00194	CbGpPWpGaD
Ergotamine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.34e-05	0.00193	CbGpPWpGaD
Ergotamine—HTR1F—GPCR downstream signaling—IL5—allergic rhinitis	4.3e-05	0.00191	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—PTGDR2—allergic rhinitis	4.25e-05	0.00189	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—CCL11—allergic rhinitis	4.23e-05	0.00188	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.22e-05	0.00187	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—TAC1—allergic rhinitis	4.2e-05	0.00187	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—PTGDR2—allergic rhinitis	4.18e-05	0.00186	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.15e-05	0.00184	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	4.13e-05	0.00183	CbGpPWpGaD
Ergotamine—HTR1E—GPCR downstream signaling—IL5—allergic rhinitis	4.06e-05	0.0018	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR ligand binding—TAC1—allergic rhinitis	4.05e-05	0.0018	CbGpPWpGaD
Ergotamine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—allergic rhinitis	4.03e-05	0.00179	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	4.01e-05	0.00178	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.99e-05	0.00177	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—TAC1—allergic rhinitis	3.96e-05	0.00176	CbGpPWpGaD
Ergotamine—HTR1F—Signaling by GPCR—IL5—allergic rhinitis	3.91e-05	0.00174	CbGpPWpGaD
Ergotamine—HTR1A—GPCR ligand binding—TAC1—allergic rhinitis	3.91e-05	0.00174	CbGpPWpGaD
Ergotamine—HTR2C—GPCR ligand binding—TAC1—allergic rhinitis	3.89e-05	0.00173	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.88e-05	0.00172	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.83e-05	0.0017	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.82e-05	0.0017	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—PTGDR2—allergic rhinitis	3.77e-05	0.00168	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.75e-05	0.00167	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR ligand binding—TAC1—allergic rhinitis	3.72e-05	0.00165	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—CCL11—allergic rhinitis	3.7e-05	0.00164	CbGpPWpGaD
Ergotamine—HTR1E—Signaling by GPCR—IL5—allergic rhinitis	3.69e-05	0.00164	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.64e-05	0.00162	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—PTGDR2—allergic rhinitis	3.62e-05	0.00161	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—CCL11—allergic rhinitis	3.62e-05	0.00161	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.61e-05	0.0016	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CYSLTR1—allergic rhinitis	3.54e-05	0.00157	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.52e-05	0.00156	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.52e-05	0.00156	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—PTGDR2—allergic rhinitis	3.47e-05	0.00154	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.46e-05	0.00154	CbGpPWpGaD
Ergotamine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	3.43e-05	0.00152	CbGpPWpGaD
Ergotamine—DRD2—GPCR ligand binding—TAC1—allergic rhinitis	3.43e-05	0.00152	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—CCL11—allergic rhinitis	3.42e-05	0.00152	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—CCL11—allergic rhinitis	3.4e-05	0.00151	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.39e-05	0.00151	CbGpPWpGaD
Ergotamine—HTR2A—GPCR ligand binding—TAC1—allergic rhinitis	3.37e-05	0.0015	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—IL5—allergic rhinitis	3.36e-05	0.00149	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CYSLTR1—allergic rhinitis	3.34e-05	0.00148	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR ligand binding—TAC1—allergic rhinitis	3.3e-05	0.00147	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—CYSLTR1—allergic rhinitis	3.28e-05	0.00146	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.26e-05	0.00145	CbGpPWpGaD
Ergotamine—SLC6A2—NRF2 pathway—TGFB1—allergic rhinitis	3.23e-05	0.00143	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—CCL11—allergic rhinitis	3.22e-05	0.00143	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—PTGDR2—allergic rhinitis	3.2e-05	0.00142	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—CCL11—allergic rhinitis	3.17e-05	0.00141	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—PTGDR2—allergic rhinitis	3.15e-05	0.0014	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.15e-05	0.0014	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.14e-05	0.0014	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3.13e-05	0.00139	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—PTGDR2—allergic rhinitis	3.08e-05	0.00137	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR ligand binding—TAC1—allergic rhinitis	3.07e-05	0.00136	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—CYSLTR1—allergic rhinitis	3e-05	0.00133	CbGpPWpGaD
Ergotamine—HTR1A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	2.98e-05	0.00132	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—TAC1—allergic rhinitis	2.96e-05	0.00131	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.96e-05	0.00131	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—TAC1—allergic rhinitis	2.9e-05	0.00129	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—PTGDR2—allergic rhinitis	2.88e-05	0.00128	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—PTGDR2—allergic rhinitis	2.86e-05	0.00127	CbGpPWpGaD
Ergotamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—allergic rhinitis	2.86e-05	0.00127	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—CCL11—allergic rhinitis	2.86e-05	0.00127	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.86e-05	0.00127	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.84e-05	0.00126	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—PTGDR2—allergic rhinitis	2.82e-05	0.00125	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.76e-05	0.00123	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—CCL11—allergic rhinitis	2.76e-05	0.00123	CbGpPWpGaD
Ergotamine—HTR1D—GPCR downstream signaling—IL5—allergic rhinitis	2.75e-05	0.00122	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—CCL11—allergic rhinitis	2.74e-05	0.00122	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—TAC1—allergic rhinitis	2.72e-05	0.00121	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.72e-05	0.00121	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.72e-05	0.00121	CbGpPWpGaD
Ergotamine—HTR1B—GPCR downstream signaling—IL5—allergic rhinitis	2.69e-05	0.0012	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—TAC1—allergic rhinitis	2.69e-05	0.00119	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.66e-05	0.00118	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—PTGDR2—allergic rhinitis	2.65e-05	0.00118	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—TAC1—allergic rhinitis	2.63e-05	0.00117	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—CCL11—allergic rhinitis	2.63e-05	0.00117	CbGpPWpGaD
Ergotamine—HTR2A—SIDS Susceptibility Pathways—NFKB1—allergic rhinitis	2.57e-05	0.00114	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—IL5—allergic rhinitis	2.55e-05	0.00113	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—TAC1—allergic rhinitis	2.53e-05	0.00113	CbGpPWpGaD
Ergotamine—HTR2B—GPCR downstream signaling—IL5—allergic rhinitis	2.53e-05	0.00112	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.51e-05	0.00111	CbGpPWpGaD
Ergotamine—HTR1D—Signaling by GPCR—IL5—allergic rhinitis	2.5e-05	0.00111	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TAC1—allergic rhinitis	2.48e-05	0.0011	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—CYSLTR1—allergic rhinitis	2.47e-05	0.0011	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—TAC1—allergic rhinitis	2.47e-05	0.0011	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.47e-05	0.0011	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—PTGDR2—allergic rhinitis	2.47e-05	0.0011	CbGpPWpGaD
Ergotamine—HTR1B—Signaling by GPCR—IL5—allergic rhinitis	2.45e-05	0.00109	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—CCL11—allergic rhinitis	2.42e-05	0.00108	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.42e-05	0.00107	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—CCL11—allergic rhinitis	2.38e-05	0.00106	CbGpPWpGaD
Ergotamine—ADRA1D—GPCR downstream signaling—IL5—allergic rhinitis	2.35e-05	0.00105	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TAC1—allergic rhinitis	2.34e-05	0.00104	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—CCL11—allergic rhinitis	2.33e-05	0.00104	CbGpPWpGaD
Ergotamine—ABCB1—Allograft Rejection—TGFB1—allergic rhinitis	2.32e-05	0.00103	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—IL5—allergic rhinitis	2.31e-05	0.00103	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—TAC1—allergic rhinitis	2.3e-05	0.00102	CbGpPWpGaD
Ergotamine—HTR2B—Signaling by GPCR—IL5—allergic rhinitis	2.3e-05	0.00102	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—TAC1—allergic rhinitis	2.29e-05	0.00102	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CYSLTR1—allergic rhinitis	2.26e-05	0.00101	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CYSLTR1—allergic rhinitis	2.25e-05	0.000997	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—PTGDR2—allergic rhinitis	2.23e-05	0.00099	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.22e-05	0.000984	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—TAC1—allergic rhinitis	2.21e-05	0.000981	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—TAC1—allergic rhinitis	2.2e-05	0.000976	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—CCL11—allergic rhinitis	2.18e-05	0.000971	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—IL5—allergic rhinitis	2.18e-05	0.000967	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—CCL11—allergic rhinitis	2.17e-05	0.000963	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—PTGDR2—allergic rhinitis	2.15e-05	0.000955	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—CCL11—allergic rhinitis	2.14e-05	0.00095	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—PTGDR2—allergic rhinitis	2.14e-05	0.00095	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling by GPCR—IL5—allergic rhinitis	2.14e-05	0.00095	CbGpPWpGaD
Ergotamine—ADRA2B—GPCR downstream signaling—IL5—allergic rhinitis	2.13e-05	0.000944	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—TAC1—allergic rhinitis	2.1e-05	0.000934	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CYSLTR1—allergic rhinitis	2.08e-05	0.000924	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—TAC1—allergic rhinitis	2.08e-05	0.000923	CbGpPWpGaD
Ergotamine—HTR1A—GPCR downstream signaling—IL5—allergic rhinitis	2.05e-05	0.000912	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—PTGDR2—allergic rhinitis	2.05e-05	0.00091	CbGpPWpGaD
Ergotamine—HTR2C—GPCR downstream signaling—IL5—allergic rhinitis	2.04e-05	0.000907	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—CCL11—allergic rhinitis	2.01e-05	0.000893	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—TAC1—allergic rhinitis	2e-05	0.000891	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—TAC1—allergic rhinitis	1.99e-05	0.000886	CbGpPWpGaD
Ergotamine—ADRA1B—GPCR downstream signaling—IL5—allergic rhinitis	1.95e-05	0.000868	CbGpPWpGaD
Ergotamine—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.94e-05	0.000864	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—TAC1—allergic rhinitis	1.94e-05	0.000861	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CYSLTR1—allergic rhinitis	1.94e-05	0.00086	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling by GPCR—IL5—allergic rhinitis	1.93e-05	0.000858	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—TAC1—allergic rhinitis	1.91e-05	0.000848	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.91e-05	0.000847	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—PTGDR2—allergic rhinitis	1.89e-05	0.000839	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—CCL11—allergic rhinitis	1.87e-05	0.000831	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—TAC1—allergic rhinitis	1.87e-05	0.00083	CbGpPWpGaD
Ergotamine—HTR1A—Signaling by GPCR—IL5—allergic rhinitis	1.86e-05	0.000828	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.86e-05	0.000825	CbGpPWpGaD
Ergotamine—HTR2C—Signaling by GPCR—IL5—allergic rhinitis	1.85e-05	0.000824	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—PTGDR2—allergic rhinitis	1.82e-05	0.000808	CbGpPWpGaD
Ergotamine—DRD2—GPCR downstream signaling—IL5—allergic rhinitis	1.8e-05	0.0008	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling by GPCR—IL5—allergic rhinitis	1.77e-05	0.000788	CbGpPWpGaD
Ergotamine—HTR2A—GPCR downstream signaling—IL5—allergic rhinitis	1.77e-05	0.000788	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—TAC1—allergic rhinitis	1.76e-05	0.000782	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.75e-05	0.000777	CbGpPWpGaD
Ergotamine—ADRA1A—GPCR downstream signaling—IL5—allergic rhinitis	1.74e-05	0.000771	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—TAC1—allergic rhinitis	1.73e-05	0.000771	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—TAC1—allergic rhinitis	1.73e-05	0.000769	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—TAC1—allergic rhinitis	1.7e-05	0.000753	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—PTGDR2—allergic rhinitis	1.69e-05	0.000751	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—CCL11—allergic rhinitis	1.69e-05	0.00075	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.69e-05	0.00075	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CYSLTR1—allergic rhinitis	1.68e-05	0.000746	CbGpPWpGaD
Ergotamine—DRD2—Signaling by GPCR—IL5—allergic rhinitis	1.64e-05	0.000727	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—CCL11—allergic rhinitis	1.63e-05	0.000724	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—SMAD3—allergic rhinitis	1.62e-05	0.000722	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—CCL11—allergic rhinitis	1.62e-05	0.00072	CbGpPWpGaD
Ergotamine—ADRA2A—GPCR downstream signaling—IL5—allergic rhinitis	1.61e-05	0.000717	CbGpPWpGaD
Ergotamine—HTR2A—Signaling by GPCR—IL5—allergic rhinitis	1.61e-05	0.000715	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CYSLTR1—allergic rhinitis	1.61e-05	0.000714	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TAC1—allergic rhinitis	1.59e-05	0.000705	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling by GPCR—IL5—allergic rhinitis	1.58e-05	0.0007	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—TAC1—allergic rhinitis	1.58e-05	0.0007	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TAC1—allergic rhinitis	1.55e-05	0.000691	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—CCL11—allergic rhinitis	1.55e-05	0.00069	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—SMAD3—allergic rhinitis	1.53e-05	0.000681	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CYSLTR1—allergic rhinitis	1.48e-05	0.000658	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—IL5—allergic rhinitis	1.48e-05	0.000656	CbGpPWpGaD
Ergotamine—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.48e-05	0.000656	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling by GPCR—IL5—allergic rhinitis	1.46e-05	0.000651	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TAC1—allergic rhinitis	1.46e-05	0.000649	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.46e-05	0.000648	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—IL5—allergic rhinitis	1.45e-05	0.000642	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—CCL11—allergic rhinitis	1.43e-05	0.000636	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.43e-05	0.000634	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—CCL11—allergic rhinitis	1.41e-05	0.000626	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—CCL11—allergic rhinitis	1.38e-05	0.000612	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.38e-05	0.000612	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TAC1—allergic rhinitis	1.36e-05	0.000604	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—IL5—allergic rhinitis	1.36e-05	0.000603	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CYSLTR1—allergic rhinitis	1.33e-05	0.000589	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—CCL11—allergic rhinitis	1.28e-05	0.000569	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—IL5—allergic rhinitis	1.26e-05	0.000561	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TAC1—allergic rhinitis	1.23e-05	0.000545	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TAC1—allergic rhinitis	1.18e-05	0.000526	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TAC1—allergic rhinitis	1.18e-05	0.000523	CbGpPWpGaD
Ergotamine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.15e-05	0.000509	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—IL5—allergic rhinitis	1.14e-05	0.000507	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TAC1—allergic rhinitis	1.13e-05	0.000501	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—IL5—allergic rhinitis	1.1e-05	0.000489	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—IL5—allergic rhinitis	1.1e-05	0.000487	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—IL5—allergic rhinitis	1.05e-05	0.000466	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TAC1—allergic rhinitis	1.04e-05	0.000462	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—SMAD3—allergic rhinitis	1.04e-05	0.000461	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TAC1—allergic rhinitis	1.02e-05	0.000454	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—SMAD3—allergic rhinitis	1.02e-05	0.000452	CbGpPWpGaD
Ergotamine—ADRA2B—Hemostasis—TGFB1—allergic rhinitis	1e-05	0.000445	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TAC1—allergic rhinitis	1e-05	0.000445	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—IL5—allergic rhinitis	9.67e-06	0.000429	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—SMAD3—allergic rhinitis	9.55e-06	0.000424	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—IL5—allergic rhinitis	9.51e-06	0.000423	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—IL5—allergic rhinitis	9.31e-06	0.000414	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TAC1—allergic rhinitis	9.31e-06	0.000413	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—SMAD3—allergic rhinitis	8.89e-06	0.000395	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—IL5—allergic rhinitis	8.65e-06	0.000384	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—NFKB1—allergic rhinitis	8.26e-06	0.000367	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—SMAD3—allergic rhinitis	8.03e-06	0.000357	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—NFKB1—allergic rhinitis	7.79e-06	0.000346	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—SMAD3—allergic rhinitis	7.75e-06	0.000344	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—SMAD3—allergic rhinitis	7.71e-06	0.000342	CbGpPWpGaD
Ergotamine—ADRA2A—Hemostasis—TGFB1—allergic rhinitis	7.61e-06	0.000338	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—SMAD3—allergic rhinitis	7.38e-06	0.000328	CbGpPWpGaD
Ergotamine—HTR1F—Signaling Pathways—TGFB1—allergic rhinitis	6.88e-06	0.000306	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—SMAD3—allergic rhinitis	6.8e-06	0.000302	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—SMAD3—allergic rhinitis	6.69e-06	0.000297	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—SMAD3—allergic rhinitis	6.55e-06	0.000291	CbGpPWpGaD
Ergotamine—HTR1E—Signaling Pathways—TGFB1—allergic rhinitis	6.49e-06	0.000288	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—SMAD3—allergic rhinitis	6.09e-06	0.000271	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—NFKB1—allergic rhinitis	5.28e-06	0.000235	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—NFKB1—allergic rhinitis	5.17e-06	0.00023	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—NFKB1—allergic rhinitis	4.86e-06	0.000216	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—NFKB1—allergic rhinitis	4.52e-06	0.000201	CbGpPWpGaD
Ergotamine—HTR1D—Signaling Pathways—TGFB1—allergic rhinitis	4.4e-06	0.000195	CbGpPWpGaD
Ergotamine—HTR1B—Signaling Pathways—TGFB1—allergic rhinitis	4.31e-06	0.000191	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—NFKB1—allergic rhinitis	4.08e-06	0.000181	CbGpPWpGaD
Ergotamine—HTR2B—Signaling Pathways—TGFB1—allergic rhinitis	4.05e-06	0.00018	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—NFKB1—allergic rhinitis	3.94e-06	0.000175	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—NFKB1—allergic rhinitis	3.92e-06	0.000174	CbGpPWpGaD
Ergotamine—ADRA1D—Signaling Pathways—TGFB1—allergic rhinitis	3.76e-06	0.000167	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—NFKB1—allergic rhinitis	3.75e-06	0.000167	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—NFKB1—allergic rhinitis	3.46e-06	0.000154	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—NFKB1—allergic rhinitis	3.4e-06	0.000151	CbGpPWpGaD
Ergotamine—ADRA2B—Signaling Pathways—TGFB1—allergic rhinitis	3.4e-06	0.000151	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—NFKB1—allergic rhinitis	3.33e-06	0.000148	CbGpPWpGaD
Ergotamine—HTR1A—Signaling Pathways—TGFB1—allergic rhinitis	3.28e-06	0.000146	CbGpPWpGaD
Ergotamine—HTR2C—Signaling Pathways—TGFB1—allergic rhinitis	3.26e-06	0.000145	CbGpPWpGaD
Ergotamine—ADRA1B—Signaling Pathways—TGFB1—allergic rhinitis	3.12e-06	0.000139	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—NFKB1—allergic rhinitis	3.1e-06	0.000138	CbGpPWpGaD
Ergotamine—DRD2—Signaling Pathways—TGFB1—allergic rhinitis	2.88e-06	0.000128	CbGpPWpGaD
Ergotamine—HTR2A—Signaling Pathways—TGFB1—allergic rhinitis	2.83e-06	0.000126	CbGpPWpGaD
Ergotamine—ADRA1A—Signaling Pathways—TGFB1—allergic rhinitis	2.78e-06	0.000123	CbGpPWpGaD
Ergotamine—ADRA2A—Signaling Pathways—TGFB1—allergic rhinitis	2.58e-06	0.000115	CbGpPWpGaD
